2.3250
+0.0100
+(0.43%)
At close: January 31 at 5:35:00 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-81,614.0000
-81,614.0000
-44,928.0000
-47,629.0000
-30,590.0000
Investing Cash Flow
-7,731.0000
-7,731.0000
8,868.0000
-1,793.0000
-8,557.0000
Financing Cash Flow
29,081.0000
29,081.0000
37,268.0000
25,447.0000
111,674.0000
End Cash Position
26,918.0000
26,918.0000
86,736.0000
86,553.0000
105,687.0000
Capital Expenditure
-540.0000
-540.0000
-561.0000
-534.0000
-292.0000
Issuance of Capital Stock
28,079.0000
28,079.0000
8,827.0000
25,475.0000
101,782.0000
Issuance of Debt
--
--
30,209.0000
--
9,979.0000
Repayment of Debt
-4,097.0000
-4,097.0000
-1,768.0000
-28.0000
-87.0000
Free Cash Flow
-82,154.0000
-82,154.0000
-45,489.0000
-48,163.0000
-30,882.0000
12/31/2020 - 2/15/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MEB.BE Medincell SA
15.72
+1.81%
ABVX.PA ABIVAX Société Anonyme
6.04
+2.90%
MEDCL.PA MedinCell S.A.
15.74
+1.29%
GLPG.AS Galapagos NV
22.16
-0.09%
ARMP Armata Pharmaceuticals, Inc.
2.0000
-2.44%
NANO.PA Nanobiotix S.A.
3.5000
+2.10%
UCB.BR UCB SA
188.20
-0.61%
NBTX Nanobiotix S.A.
3.4850
-1.83%
HNSA.ST Hansa Biopharma AB (publ)
34.46
+3.73%
ABVX ABIVAX Société Anonyme
5.97
+1.19%